Hepatic encephalopathy in end-stage liver disease #188

Journal of Palliative Medicine

Volumn 11, Issue 10, 2008, Pages 1341-1342

  Childers, Julie Wilson ^a   Arnold, Robert M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMMONIA; LACTITOL; LACTULOSE; NEOMYCIN; PARACETAMOL; RIFAXIMIN; VANCOMYCIN;

ABDOMINAL CRAMP; ALCOHOL WITHDRAWAL; AMMONIA BLOOD LEVEL; BACTERIAL PERITONITIS; DIARRHEA; DRUG COST; DRUG TOLERANCE; FLATULENCE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; KIDNEY FAILURE; LIVER DISEASE; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; PAIN; SHORT SURVEY;

CHRONIC DISEASE; COMA; CONFUSION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER DISEASES; PERSONALITY DISORDERS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 58149218436     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2008.2816     Document Type: Short Survey

References (11)

1. Blei AT, Cordoba J: Practice guidelines: Hepatic encephalopathy. Am J Gastroenterology 2001;96:1968-1976.
2. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J:. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30:890-895.
3. Russo MW, LaPointe-Rudow D, Kinkhabwaa M, Emond J, Brown RS: Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transplant 2004;4:427-431.
4. Fessel JM, Conn HO: An analysis of the causes and prevention of hepatic coma. Gastroenterology 1972;62:191.
5. Als-Nielsen B, Gluud LL, Gluud C: Non-absorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev 2004;(2):CD003044.
6. Mas A, Rodes J, Sunyer L, Rodrigo L, Planas R, Vargas V, Castells L, Rodríguez-Martínez D, Fernández-Rodríguez C, Coll I, Pardo A; Spanish Association for the Study of the Liver Hepatic Encephalopathy Cooperative Group: Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: Results of a randomized, double-blinded, double-dummy, controlled clinical trial. J Hepatol 2003;38:51-58.
7. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C: Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2003;(2):CD001939.
8. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G: Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An Italian multicenter double-blind, placebo-controlled, cross-over study. Hepatology 1998;28:374-378.
9. Als-Nielsen B, Gluud LL, Gluud C: Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy. Cochrane Database Syst Rev 2004;(2):CD002798.
10. Cordoba J, Lopez-Hellin J, Planas M, Sabín P, Sanpedro F, Castro F, Esteban R, Guardia J: Normal protein diet for episodic hepatic encephalopathy. J Hepatol. 2004;41: 38-43.
11. Larson AM, Curtis JR: Integrating palliative care for liver transplant candidates: "Too well for transplant, too sick for life." JAMA 2006;295:2168-2176.